Prosecution Insights
Last updated: April 19, 2026

Apellis Pharmaceuticals, Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18027331 METHODS OF TREATING EYE DISORDERS SABILA, MERCY HELLEN 1654 Non-Final OA Mar 20, 2023
17798339 RNAS FOR COMPLEMENT INHIBITION HUDSON, AMY ROSE 1636 Final Rejection Aug 09, 2022

Managing Apellis Pharmaceuticals, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month